This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
4 Medical Product Stocks to Buy From a Challenging Industry
by Indrajit Bandyopadhyay
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.
PAHCPositive Net Change BLFSPositive Net Change OMERPositive Net Change BWAYNegative Net Change
medical medical-devices
CHE Stock Up Following Q1 Earnings & Revenue Beat, Margins Down
by Zacks Equity Research
Chemed stock jumps after Q1 earnings and revenues beat estimates despite margin contraction and mixed segment performance across VITAS and Roto-Rooter.
ISRGPositive Net Change CHENegative Net Change GMEDNegative Net Change PAHCPositive Net Change
earnings medical medical-devices
Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings?
by Zacks Equity Research
GeneDx heads into Q1 earnings results with strong exome and genome momentum, supported by expanding adoption and a growing rare-disease data advantage.
AGENNegative Net Change ENSGNegative Net Change EHCNegative Net Change WGSPositive Net Change
earnings medical medical-devices
Top Stock Reports for Caterpillar, Texas Instruments & Boeing
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Caterpillar Inc. (CAT), Texas Instruments Inc. (TXN) and The Boeing Company (BA), as well as two micro-cap stocks Kewaunee Scientific Corp. (KEQU) and Vaso Corp. (VASO).
BAPositive Net Change TXNPositive Net Change CATPositive Net Change CSXPositive Net Change AMGNPositive Net Change SCHWNegative Net Change VASONegative Net Change KEQUNegative Net Change
aerospace computers industrial-products medical-devices semiconductor
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
by Zacks Equity Research
DexCom's Q1 results may see strong growth from G7 uptake and CGM demand, but pricing mix and rising investments could weigh on margins.
HSICNegative Net Change DXCMPositive Net Change IDXXPositive Net Change MBOTPositive Net Change
medical medical-devices
Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1?
by Indrajit Bandyopadhyay
Intuitive Surgical's strong Q1 results, rising procedures, and raised outlook highlight accelerating growth, while Boston Scientific faces headwinds and tempered guidance.
BSXPositive Net Change ISRGPositive Net Change
medical medical-devices
SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year Study
by Zacks Equity Research
Smith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.
SNNNegative Net Change CAHNegative Net Change GMEDNegative Net Change PAHCPositive Net Change
medical medical-devices
GEHC Moves Manganese-Based MRI Contrast Agent Into Phase 2/3 Trial
by Zacks Equity Research
GE HealthCare doses first patient in Phase 2/3 LUMINA trial for mangaciclanol, a manganese MRI contrast agent with FDA Fast Track status.
CAHNegative Net Change GMEDNegative Net Change PAHCPositive Net Change GEHCPositive Net Change
medical medical-devices
Can Strength in Global High-Tech Drive ECL Stock Before Q1 Earnings?
by Zacks Equity Research
Ecolab's Q1 performance is likely to benefit from Global High-Tech momentum and digital water demand, as pricing actions aim to cushion rising energy costs.
ECLPositive Net Change CENegative Net Change LINPositive Net Change HWKNPositive Net Change
earnings medical medical-devices
Monarch Casino (MCRI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MCRINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines